Skip to main content

Is Opdivo a chemotherapy or immunotherapy drug?

Medically reviewed by Carmen Pope, BPharm. Last updated on May 30, 2022.

Official answer


Opdivo is an immunotherapy treatment. It belongs to the class of medicines known as checkpoint inhibitors and works by blocking the PD-1 (programmed death receptor-1) pathway to help prevent cancer cells from hiding from the immune system, boosting the immune system's response against cancer.

  • Opdivo (nivolumab) Updated 05/2022. E.R. Squibb & Sons, L.L.C.

Related medical questions

Drug information

Related support groups

  • Opdivo (16 questions, 51 members)